Group B Streptococcus
Streptococcus agalactiae
General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.
Overview
A Gram-positive coccus that colonizes the gut and genital tract.
Infections
Urinary tract infection (especially in pregnancy, older adults and diabetes), skin and soft-tissue infection, bloodstream infection, neonatal sepsis and meningitis.
Signs and symptoms
Urinary symptoms; fever; skin infection in diabetic foot.
Antibiotic and antimicrobial resistance
Susceptible to penicillin; clindamycin and macrolide resistance are common (erm).
Treatment considerations
Penicillin or ampicillin. In pregnancy, group B Streptococcus in urine at any count indicates intrapartum antibiotic prophylaxis.
Sources
- CDC. Group B strep disease.
Sources accessed November 2026. Links open external sites that InnovexLab does not control.
Medical disclaimer
This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.
Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.